drugset / Trial / NCT03618537
Ixazomib Maintenance Study in Patients With AL Amyloidosis
Phase 2
Active not recruiting
17 enrolled
Memorial Sloan Kettering Cancer Center
Tufts Medical Center · collabVanderbilt University Medical Center · collab
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to learn if Ixazomib maintenance treatment (chemotherapy) works to control the disease. Through this study, the investigators hope to learn more about ways to prevent or delay relapse of AL Amyloidosis.
Timeline
- Start
- 2018-08-02
- Primary completion
- 2026-08
- Completion
- 2026-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ixazomib | Unknown | 4 mg | Oral |
| Background | Dexamethasone | Small molecule | 4 mg | — |
| Background | Dexamethasone | Small molecule | 12 mg | — |